Cargando…

Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid

Caffeine is a promising drug for the management of neurodegenerative diseases such as Parkinson’s disease (PD), demonstrating neuroprotective properties that have been attributed to its interaction with the basal ganglia adenosine A(2A) receptor (A(2A)R). However, the doses needed to exert these neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Dueñas, Víctor, Azuaje, Jhonny, Morató, Xavier, Cordobilla, Begoña, Domingo, Joan Carles, Sotelo, Eddy, Ciruela, Francisco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155394/ https://www.ncbi.nlm.nih.gov/pubmed/28264466 http://dx.doi.org/10.3390/molecules22030366

Ejemplares similares

Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism
por: Gómez-Soler, Maricel, et al.
Publicado: (2018)

Inadequate Content of Docosahexaenoic Acid (DHA) of Donor Human Milk for Feeding Preterm Infants: A Comparison with Mother’s Own Milk at Different Stages of Lactation
por: Castillo, Félix, et al.
Publicado: (2021)

Erythrocyte Membrane Docosahexaenoic Acid (DHA) and Lipid Profile in Preterm Infants at Birth and Over the First Month of Life: A Comparative Study with Infants at Term
por: Castillo Salinas, Félix, et al.
Publicado: (2022)

Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice
por: Mancera, Pilar, et al.
Publicado: (2017)

A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease
por: Boyer-Diaz, Zoe, et al.
Publicado: (2019)

Changes of Erythrocyte Fatty Acids after Supplementation with Highly Concentrated Docosahexaenoic Acid (DHA) in Pediatric Cystic Fibrosis: A Randomized Double-Blind Controlled Trial
por: Ayats-Vidal, Roser, et al.
Publicado: (2023)

Portraying G Protein-Coupled Receptors with Fluorescent Ligands
por: Ciruela, Francisco, et al.
Publicado: (2014)

Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A(2A) and dopamine D(2) receptors
por: Guixà-González, Ramon, et al.
Publicado: (2016)

Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes in Response to Omega-3 Supplementation: A Dose-Response Pilot Study
por: Drobnic, Franchek, et al.
Publicado: (2017)

Special Issue: Adenosine Receptors
por: Ciruela, Francisco, et al.
Publicado: (2017)

Computer-aided design of multi-target ligands at A(1)R, A(2A)R and PDE10A, key proteins in neurodegenerative diseases
por: Kalash, Leen, et al.
Publicado: (2017)

Uncovering Caffeine’s Adenosine A(2A) Receptor Inverse Agonism in Experimental Parkinsonism
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2014)

Development of a Novel σ(1) Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells
por: Morató, Xavier, et al.
Publicado: (2023)

Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
por: Castro-Marrero, Jesús, et al.
Publicado: (2022)

The Parkinson’s disease-associated GPR37 receptor interacts with striatal adenosine A(2A) receptor controlling its cell surface expression and function in vivo
por: Morató, Xavier, et al.
Publicado: (2017)

Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial
por: Rodríguez, Celestino, et al.
Publicado: (2019)

Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)

Intravitreal Docosahexaenoic Acid in a Rabbit Model: Preclinical Safety Assessment
por: Dolz-Marco, Rosa, et al.
Publicado: (2014)

G protein-coupled receptor 37 (GPR37) emerges as an important modulator of adenosinergic transmission in the striatum
por: Morató, Xavier, et al.
Publicado: (2019)

Adenosine A(1)-A(2A) Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2017)

Bivalent Ligands for Protein Degradation in Drug Discovery
por: Scheepstra, Marcel, et al.
Publicado: (2019)

Exploring the Effect of Halogenation in a Series of Potent and Selective A(2B) Adenosine Receptor Antagonists
por: Prieto-Díaz, Rubén, et al.
Publicado: (2022)

Effect of Melatonin Plus Zinc Supplementation on Fatigue Perception in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
por: Castro-Marrero, Jesús, et al.
Publicado: (2021)

Antioxidant Activity and Neuroprotective Role of Docosahexaenoic Acid (DHA) Supplementation in Eye Diseases That Can Lead to Blindness: A Narrative Review
por: Lafuente, María, et al.
Publicado: (2021)

Antioxidant and Anti-Inflammatory Effects of Oral Supplementation with a Highly-Concentrated Docosahexaenoic Acid (DHA) Triglyceride in Patients with Keratoconus: A Randomized Controlled Preliminary Study
por: Peris-Martínez, Cristina, et al.
Publicado: (2023)

Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H(3)-Ligands
por: Pala, Daniele, et al.
Publicado: (2014)

Pridopidine Reverses Phencyclidine-Induced Memory Impairment
por: Sahlholm, Kristoffer, et al.
Publicado: (2018)

Photomodulation of G Protein-Coupled Adenosine Receptors by a Novel Light-Switchable Ligand
por: Bahamonde, María Isabel, et al.
Publicado: (2014)

Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: prospective controlled study of macular function by fundus microperimetry
por: Rodríguez González-Herrero, María Elena, et al.
Publicado: (2018)

The size matters? A computational tool to design bivalent ligands
por: Pérez-Benito, Laura, et al.
Publicado: (2018)

Effects of Oral Supplementation with Docosahexaenoic Acid (DHA) plus Antioxidants in Pseudoexfoliative Glaucoma: A 6-Month Open-Label Randomized Trial
por: Romeo Villadóniga, Stéphanie, et al.
Publicado: (2018)

THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA
por: Lafuente, María, et al.
Publicado: (2019)

Ecto-GPR37: a potential biomarker for Parkinson’s disease
por: Morató, Xavier, et al.
Publicado: (2021)

Examining the influence of specificity ligands and ATP-competitive ligands on the overall effectiveness of bivalent kinase inhibitors
por: Wong, Margaret L., et al.
Publicado: (2017)

Exploring the signaling space of a GPCR using bivalent ligands with a rigid oligoproline backbone
por: Romantini, Nina, et al.
Publicado: (2021)

Neuromodulatory Effects of Guanine-Based Purines in Health and Disease
por: Tasca, Carla I., et al.
Publicado: (2018)

Overcoming the Challenges of Detecting GPCR Oligomerization in the Brain
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2022)

Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2020)

Potent and Subtype-Selective Dopamine D(2) Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
por: Mallo-Abreu, Ana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h1ldc8gj4k8v400qvl5hk546oh